BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Tenacia Biotechnology readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Tenacia Biotechnology's drugs run
 \, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07219407-8911@assetmemo.bio
DTSTAMP:20261121T005943Z
DTSTART;VALUE=DATE:20280203
DTEND;VALUE=DATE:20280204
SUMMARY:RAP-219: Phase 2 readout est. (NCT07219407)
DESCRIPTION:RAP-219\, phase 2\, Epilepsy.\nStudy: A Long-term Study of the 
 Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures\nE
 stimated primary completion: 3 February 2028. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/rap-219#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07219407
URL:https://assetmemo.bio/drug/rap-219#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07563881-8911@assetmemo.bio
DTSTAMP:20261121T005943Z
DTSTART;VALUE=DATE:20290731
DTEND;VALUE=DATE:20290801
SUMMARY:RAP-219: Phase 3 readout est. (NCT07563881)
DESCRIPTION:RAP-219\, phase 3\, Epilepsy.\nStudy: Study Evaluating the Effi
 cacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS
 -1\nEstimated primary completion: July 2029. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/rap-219#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07563881
URL:https://assetmemo.bio/drug/rap-219#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07594119-8911@assetmemo.bio
DTSTAMP:20261121T005943Z
DTSTART;VALUE=DATE:20290731
DTEND;VALUE=DATE:20290801
SUMMARY:RAP-219: Phase 3 readout est. (NCT07594119)
DESCRIPTION:RAP-219\, phase 3\, Epilepsy.\nStudy: Study Evaluating the Effi
 cacy and Safety of RAP-219 in Adult Participants With Focal Seizures\nEsti
 mated primary completion: July 2029. This is a ClinicalTrials.gov estimate
 \, not a confirmed readout date\, and it can move.\nDrug page: https://ass
 etmemo.bio/drug/rap-219#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT07594119
URL:https://assetmemo.bio/drug/rap-219#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
